Natural History of Clostridioides Difficile Infection

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital Universitario de Valme

About this trial

Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.

Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.

Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age older than 18 years

New episode of Clostridioides difficile infection, based on IDSA criteria.

Disqualifiers

None

Trial population

Adult patients diagnosed of Clostridoides difficile infection

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

750 Participants
are grouped into 1 trial group
Group A: Patients diagnosed of C.difficile infection

Trial outcomes

Primary outcomes

1

CDI recurrence

Clostridioides difficile recurrence

Time frame
First 8 weeks after end of therapy
2

CDI reinfection

New episode of Clostridioides difficile infection

Time frame
Between 8 weeks after end of therapy and before 24 weeks

Secondary outcomes

1

Readmission due to CDI infection

New hospitalization related to new Clostridioides difficile infection episode

Time frame
During 24 weeks after the end of therapy

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.